Akums Drugs (India) Executives
| AKUMS Stock | 537.75 6.90 1.27% |
Akums Drugs employs about 7.5 K people. The company is managed by 12 executives with a total tenure of roughly 17584 years, averaging almost 1465.0 years of service per executive, having 628.0 employees per reported executive. Analysis of Akums Drugs' management performance can provide insight into the firm performance.
| Arvind Srivastava President President Resource |
| Sanjay Sinha President President Director |
Akums |
Akums Drugs Management Team Effectiveness
The company has return on total asset (ROA) of 0.0503 % which means that it generated a profit of $0.0503 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1817 %, meaning that it generated $0.1817 on every $100 dollars invested by stockholders. Akums Drugs' management efficiency ratios could be used to measure how well Akums Drugs manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of July 2025, Other Current Assets is likely to grow to about 2.1 B, while Total Assets are likely to drop about 38.4 B.As of the 23rd of July 2025, Common Stock Shares Outstanding is likely to drop to about 122.5 M
Akums Drugs Workforce Comparison
Akums Drugs and is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 13,573. Akums Drugs totals roughly 7,536 in number of employees claiming about 56% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Akums Drugs Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Akums Drugs Price Series Summation is a cross summation of Akums Drugs price series and its benchmark/peer.
Akums Drugs Notable Stakeholders
An Akums Drugs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Akums Drugs often face trade-offs trying to please all of them. Akums Drugs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Akums Drugs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sanjeev Jain | MD CoFounder | Profile | |
| Sandeep Jain | MD Founder | Profile | |
| Arvind Srivastava | President Resource | Profile | |
| Sanjay Sinha | President Director | Profile | |
| Amrut Medhekar | Chief Business | Profile | |
| Sunil Jaiswal | Vice Development | Profile | |
| Shantanu Chobhe | Corporate Head | Profile | |
| Sumeet Sood | Chief Officer | Profile | |
| Dharamvir Malik | Company Officer | Profile | |
| Sahil Maheshwari | General Strategy | Profile | |
| Sanjay Sharma | New Strategy | Profile | |
| Jitendra Mishra | Head Technology | Profile |
About Akums Drugs Management Performance
The success or failure of an entity such as Akums Drugs often depends on how effective the management is. Akums Drugs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Akums management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Akums management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Akums Drugs is entity of India. It is traded as Stock on NSE exchange.
Akums Drugs Workforce Analysis
Traditionally, organizations such as Akums Drugs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Akums Drugs within its industry.Akums Drugs Manpower Efficiency
Return on Akums Drugs Manpower
| Revenue Per Employee | 5.5M | |
| Revenue Per Executive | 3.4B | |
| Net Income Per Employee | 456.2K | |
| Net Income Per Executive | 286.5M | |
| Working Capital Per Employee | 1.8M | |
| Working Capital Per Executive | 1.2B |
Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.